Dashboard
Manage Tickers

KAKINETA, INC./DE

Nasdaq yumanity.com


$ 0.63 $ 0.00 (-0.15 %)    

Wednesday, 04-Sep-2024 11:36:46 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 0.659
$ 0.60 x 100
-- x --
-- - --
$ 0.33 - $ 5.39
11,918
na
8.08M
$ -0.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-21-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-31-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-24-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-31-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-15-2020 03-31-2020 10-Q
19 03-10-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 03-08-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 03-14-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-04-2017 06-30-2017 10-Q
30 05-12-2017 03-31-2017 10-Q
31 03-30-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-15-2016 06-30-2016 10-Q
34 05-13-2016 03-31-2016 10-Q
35 03-30-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

kineta-reopens-enrollment-for-vista-101-clinical-trial-evaluating-kva12123-in-patients-with-advanced-solid-tumor-cancer
Kineta Reopens Enrollment For VISTA-101 Cl...
08/19/2024 13:02:56

Effective immediately, clinical sites in the VISTA-101 Phase 1/ Phase 2 clinical trial can resume screening of patients for enr...

Core News & Articles
TuHURA Biosciences And Kintara Therapeutic...
07/08/2024 10:35:50

KVA12123 is a rationally targeted, anti-VISTA antibody checkpoint inhibitor to reverse VISTA immune suppression and remodel t...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
06/20/2024 20:31:11

why-nurix-therapeutics-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket
Why Nurix Therapeutics Shares Are Trading ...
06/17/2024 12:43:16

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
06/17/2024 12:07:49

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
06/14/2024 20:31:12

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
06/06/2024 16:31:11

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
06/05/2024 16:31:03

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/29/2024 12:06:44

kineta-provides-update-on-its-ongoing-phase-12-vista-101-clinical-trial-and-corporate-activities-received-500000-investment-from-an-existing-investor
Kineta Provides Update On Its Ongoing Phas...
05/15/2024 20:21:11

Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts ...

kineta-q1-eps-089-misses-021-estimate
Kineta Q1 EPS $(0.89) Misses $(0.21) Estimate
05/15/2024 20:20:17

Kineta (NASDAQ:KA) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.21) by 323...

kineta-says-actively-exploring-strategic-alternatives-to-maximize-value-for-all-stakeholders
Kineta Says Actively Exploring Strategic A...
05/15/2024 20:02:22

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
04/19/2024 12:08:38

why-wang--lee-group-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket
Why Wang & Lee Group Shares Are Trading Hi...
04/19/2024 09:45:48

kineta-granted-us-patent-titled-proteasome-activity-enhancing-compounds-including-methods-for-treating-cancer-or-tumors
Kineta Granted U.S. Patent Titled 'Proteas...
04/16/2024 15:35:41

https://ppubs.uspto.gov/dirsearch-public/image-conversion/convert?url=uspat/US/G73/588/119/00000001.tif&requestToken=eyJzdW...

why-medical-properties-trust-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket
Why Medical Properties Trust Shares Are Tr...
04/15/2024 09:45:11

Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced th...

why-ascent-solar-technologies-shares-are-trading-lower-by-around-50-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Ascent Solar Technologies Shares Are T...
04/10/2024 18:07:05

Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced p...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
04/10/2024 16:31:24

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/10/2024 12:09:34

why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Tilray Brands Shares Are Trading Lower...
04/09/2024 17:12:29

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION